Clinicopathological stratification of myeloid sarcoma: Differences between acute leukemia-associated, chronic myeloid neoplasm-associated, and de novo disease - A single-center study of 126 cases [0.03%]
髓系肉瘤的临床病理分层：急性白血病相关、慢性髓系肿瘤相关和原发疾病的差异——一项针对126例患者的单中心研究
Arti Agarwal,Shikhar Chohan,Dipika Bharti et al.
Arti Agarwal et al.
Background: Myeloid sarcoma is a rare extramedullary tumor of immature myeloid cells, most commonly associated with acute leukemia, but also seen in chronic myeloid neoplasms or as an isolated lesion (de novo). These diff...
Corrigendum to "17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cells" [Leuk. Res. 34, (2010), 1493-1500] [0.03%]
“17-N-烯丙基氨甲酰-17去甲氧基姜黄素诱导人类急性髓性白血病细胞产生多种反应”的勘误页（ leukemia research，2010，卷34期，第1493-1500页）
Jennifer M Napper,Vincent E Sollars
Jennifer M Napper
Published Erratum
Leukemia research. 2026 Jul 14:108280. DOI:10.1016/j.leukres.2026.108280 2026
Bioluminescent xenograft model of acute myeloid leukemia for immunotherapy preclinical studies [0.03%]
用于免疫治疗的急性髓系细胞白血病外植体模型的发光研究
Dina Senichkina,Tamara Pukhalskaia,Daria Bogdanova et al.
Dina Senichkina et al.
Accurate in vivo models that recapitulate both acute myeloid leukemia (AML) progression and human immune responses are essential for the preclinical testing of novel immunotherapies. In this study, we developed and validated a bioluminescen...
Multispecialty referral patterns to a clonal hematopoiesis clinic: Who, what, and why? [0.03%]
克隆性造血门诊的多学科转诊模式：转诊的是谁、做什么以及为什么？
Ayman Mohammad,Sushruta Iruvanti,Bridget K Marcellino et al.
Ayman Mohammad et al.
Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS) are increasingly recognized as risk factors for hematologic malignancy, cardiovascular disease, and inflammatory disorders. Whil...
A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia [0.03%]
一项八年级及以上急性髓系白血病患者临床结局的多中心真实世界研究
Toshihiro Matsukawa,Jun Nagai,Minoru Kanaya et al.
Toshihiro Matsukawa et al.
Background: Acute myeloid leukemia (AML) predominantly affects older adults; however, patients aged ≥ 80 years remain underrepresented in clinical trials, and their real-world outcomes and prognostic determinants remain ...
FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study [0.03%]
FLAG-IDA和FLAMSA在成人复发/难治急性髓系白血病和急性淋巴细胞白血病挽救治疗中的疗效比较：单中心真实世界回顾性研究
Emine Merve Savaş,Hale Hilal Bozkurt,Nevin Işıl Kemer et al.
Emine Merve Savaş et al.
Management of relapsed or refractory acute leukemia remains challenging, as allogeneic transplantation is the only curative option. Although targeted therapies are increasingly incorporated as bridge-to-transplant strategies in both AML and...
CD244 modulates bone marrow infiltrating CD8+ T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia [0.03%]
CD244调节骨髓浸润的CD8+T细胞并可作为急性髓系白血病中的预后和免疫治疗靶点
Qiang Zhuang,Cheng Chen,Jiaqian Pan et al.
Qiang Zhuang et al.
Background: The Signaling Lymphocyte Activation Molecule (SLAM) receptor family regulates immune homeostasis across diverse immune cells. This study investigates the immunomodulatory role of CD244 in CD8+T cells within th...
Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors [0.03%]
异柠檬酸脱氢酶抑制剂治疗异柠檬酸脱氢酶突变的老年人急性髓系白血病的长期缓解和生存期研究
Nilesh Kapoor,Fieke W Hoff,Clayton Jackson et al.
Nilesh Kapoor et al.
Background: Isocitrate dehydrogenase inhibitors (IDHi) for IDH-mutated acute myeloid leukemia (AML) are important treatment options for older adults in whom treatment-related toxicities are a major concern. Long-term data...
Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort [0.03%]
浆细胞样淋巴瘤的现实世界结局：PLASMABLAT-001队列的治疗方案和生存结果
Humberto Martinez-Cordero,Paola Spirko,Irma Karen Pellon et al.
Humberto Martinez-Cordero et al.
Background: Plasmablastic lymphoma (PBL) is a rare and aggressive malignancy frequently associated with human immunodeficiency virus (HIV) infection and lacking standardized treatment strategies. We developed the PLASMABL...